Literature DB >> 15764034

Erythema nodosum and antitubercular therapy.

B Kumar1, K Sandhu.   

Abstract

OBJECTIVE: To establish the efficacy of antitubercular therapy in patients with erythema nodosum with a highly positive Mantoux test.
METHODS: A retrospective analysis of all patients diagnosed with idiopathic erythema nodosum with a highly positive Mantoux reaction between 1988 and 2001 was undertaken. In the absence of any other clinical or investigative evidence of active tuberculosis they were treated with antitubercular therapy.
RESULTS: Out of a total of 52 patients diagnosed with idiopathic erythema nodosum with a strongly positive Mantoux test (average of 19 mm), data could be analyzed in only 47 patients. After treatment with antitubercular drugs, new lesions stopped appearing in 45 patients within 6-8 weeks and subsided in two. The therapy was well tolerated except for jaundice in one patient and transient urticarial lesions in another.
CONCLUSIONS: Antitubercular therapy definitely has a role in the management of patients with erythema nodosum, even in the absence of a detectable focus of tubercular infection, especially in regions where tuberculosis is endemic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15764034     DOI: 10.1080/09546630410033754

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  2 in total

Review 1.  Erythema nodosum and the risk of tuberculosis in a high incidence setting.

Authors:  Karen Bjorn-Mortensen; Karin Ladefoged; Jacob Simonsen; Sascha W Michelsen; Hans Christian F Sørensen; Anders Koch; Troels Lillebaek; Aase Bengaard Andersen; Bolette Soborg
Journal:  Int J Circumpolar Health       Date:  2016-10-25       Impact factor: 1.228

2.  Erythema nodosum as sign of primary tuberculosis.

Authors:  Eleftherios Kritsotakis
Journal:  Oxf Med Case Reports       Date:  2017-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.